December 16, 2014

Actavis on Tuesday announced the planned senior management team that will lead the global pharmaceutical company following the successful close of the acquisition of Allergan.

December 11, 2014

Are high distribution costs and overly complex regulations stifling pharmaceutical and health product suppliers’ ability to fully engage with the fast-changing healthcare marketplace? That’s one concern raised by a global survey of healthcare executives in the United States, Canada, Europe, Asia and Latin America from United Parcel Service.

December 11, 2014

After a recent spike in the prices charged for some generic drugs led to outcries from pharmacists, patient advocates and federal lawmakers, a report issued last month suggests that drug costs can be controlled if the Food and Drug Administration changes the way it handles reviews and approvals.

 
December 5, 2014

The McKesson Pharmacy Optimization team has identified the top five trends that will impact the healthcare system and health system pharmacies in 2015.

 

December 3, 2014

Health-and-wellness companies see increasing opportunity in the point-of-care channel to reach and engage with patients primed to receive information about their health.

 

November 17, 2014

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

November 17, 2014

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

November 17, 2014

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

November 17, 2014

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

October 31, 2014

The response to the current global Ebola scare from both the pharmaceutical and pharmacy industries has been nothing short of remarkable. Precautionary preparations have been made to address the Ebola concerns in the United States; several pharmaceutical manufacturers have been working around the clock toward an Ebola vaccine and treatment; and there has been an outpooring of goods that have been directed to help with the outbreak in West Africa. 

Ebola is not a problem in the United States, at least not yet (nor hopefully will it ever be), but the pharmaceutical community is stepping up to help around the world. And in the U.S., there is much being done to help the pharmacy world prepare.

 

October 22, 2014

A JAMA study noted that about two-thirds of dietary supplements recalled by the Food and Drug Administration still contained banned ingredients at least six months after being recalled.

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 15, 2014

Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?

October 15, 2014

As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.

October 13, 2014

The Tummy Company on Monday announced the formation of a scientific advisory board composed of gastroenterology and pharmaceutical specialists to provide oversight of the new liquid antacid Relief OTC.

September 29, 2014

Alliance Boots on Monday announced that China Securities Regulatory Commission has approved the group's investment in Nanjing Pharmaceutical Company Limited.

September 25, 2014

Pfizer announced on Thursday that it has completed its acquisition of the pharmaceutical development company, InnoPharma, following receipt of U.S. regulatory approval from all government authorities required by the agreement and other closing conditions.

September 24, 2014

After several challenging years, exacerbated by the implementation of the Medicare prescription drug benefit, the rate of independent pharmacy closures has calmed.

September 23, 2014

A bill has been introduced that lawmakers say would “close federal loopholes” and increase consumer access to generic drugs while boosting market competition.

September 11, 2014

Cardinal Health on Thursday announced that Michael Kaufmann has been named CFO of the company effective Nov. 11.

September 2, 2014

More than 55% of people suffer from swallowing difficulties when taking tablets or capsules, which is likely to inhibit compliance, according to an international survey conducted by Spiegel Institute Mannheim on behalf of Hermes Pharma. 

August 28, 2014

H. D. Smith on Monday announced the winners of its annual Trading Partners of the Year award, honoring select pharmaceutical and health products manufacturers who collaborate actively to grow the industry and advance patient care.

August 27, 2014

Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.

August 27, 2014

The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications.